Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.
about
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre studyIbrutinib treatment ameliorates murine chronic graft-versus-host disease.Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.Ciclosporin kinetics in children after stem cell transplantation.Conjunctival HLA-DR and CD8 expression detected by impression cytology in ocular graft versus host disease.Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.Prophylaxis of acute GVHD: manipulate the graft or the environment?Novel application of lentiviral vectors towards treatment of graft-versus-host disease.Nutritional support in patients with GVHD of the digestive tract: state of the art.NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome.Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.Previously Activated Psoralen: A Possible Novel Format of Psoralen Used in the Treatment of Graft-versus-host Disease.IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD.The effect of cyclosporine initiation time on the outcome of matched allogeneic stem-cell transplantation following fludarabine-based conditioning.Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation.The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.
P2860
Q35120338-14B97C99-C393-47AB-8755-DC0EDD712EE8Q35140097-8B051411-A01D-4EB2-A16D-679BD083130DQ35495340-4A9907B1-7D26-46EE-B504-C99AC751DDE0Q36715943-DD1B07F3-A10E-4148-93FD-915D20C3F917Q36835217-C1F77E55-02E6-4D4B-9720-D7FE346F7369Q36922221-E237E4F7-2E82-48D0-A8B2-0B469D09E1AFQ37027349-7A857C76-058B-4115-8614-7075D68A1B6CQ37051052-3184C76F-A189-4699-9747-B0DD5AC120A9Q37173456-AD64A9A6-E961-4024-AE71-93B8824A34DCQ37489887-44D83904-CCB6-40BC-B712-0C6334631C15Q38024717-DA03D8DD-E648-479C-BF0A-3BA827CFCBD3Q38057238-AB1879F1-8C63-4F37-8AB4-E039B627220BQ39748070-0A730AD7-EBB0-41FE-B61B-D78D5A5A29B4Q41469646-20E047B5-53A1-498F-84C3-83BD03F5A7C0Q46136248-0097B35B-45BD-42BA-9F0C-F9560B2A7497Q46872099-157C2DFE-03C2-4744-95CC-B6221E0D8BD0Q48031735-92643F71-0D0B-42DC-9D1B-D1074C462793Q51455474-56EECE8E-6BB1-4AA9-A905-C78A88AF18B3
P2860
Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Risk assessment in haematopoie ...... GvHD prevention and treatment.
@en
type
label
Risk assessment in haematopoie ...... GvHD prevention and treatment.
@en
prefLabel
Risk assessment in haematopoie ...... GvHD prevention and treatment.
@en
P1476
Risk assessment in haematopoie ...... GvHD prevention and treatment.
@en
P2093
Ernst Holler
P304
P356
10.1016/J.BEHA.2006.10.001
P577
2007-06-01T00:00:00Z